【24h】

The clinical outcome of bioactive-glass coated hip prostheses

机译:生物活性玻璃涂层髋关节假体的临床结果

获取原文
获取原文并翻译 | 示例

摘要

A bioactive glass, previously described in literature, was clinically tested as a coating for hip prostheses. The glass was designed to be degradable in-vivo. Early implants in humans have been performed in 1991, giving 8 years as the longest follow-up. Authors investigated the clinical performance of the cementless bioactive-glass coated stem versus a cemented un-coated one; they matched two groups who had equal: a)-stem design; b)-surgical technique; c)-sex distribution. Fifty-two implants of a bioactive-glass coated hip stems were studied. They showed a good clinical response and a decrease in early-6-months thigh pain. Only two loosening have been recorded up to now. No significative differences have been observed between cementless coated stems and cemented un-coated stems; this fact stresses the point that surgical technique and stem design are probably more important than materials alone for the good outcome of hip prostheses.
机译:先前在文献中描述过的一种生物活性玻璃已在临床上作为髋关节假体的涂层进行了测试。该玻璃被设计为可体内降解。 1991年进行了人类的早期植入,最长的随访时间为8年。作者研究了非骨水泥生物活性玻璃涂层茎与非骨水泥未涂层茎的临床表现。他们匹配了两个相等的组:a)阀杆设计; b)手术技术; c)性别分布。研究了五十二种生物活性玻璃涂层髋关节植入物。他们表现出良好的临床反应,并减轻了前六个月的大腿疼痛。迄今为止,仅记录了两次松动。在非骨水泥涂层茎和非骨水泥涂层茎之间未观察到显着差异。这一事实强调了这样的观点:对于髋关节假体的良好结果,手术技术和柄的设计可能比单独使用材料更为重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号